Crinetics Pharmaceuticals, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Crinetics Pharmaceuticals, Inc. (CRNX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$2.77 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-03
- Crinetics Pharmaceuticals, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $9.29M, a 25.76% decline year-over-year.
- Crinetics Pharmaceuticals, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$12.06M.
- Crinetics Pharmaceuticals, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-06-30 was $12.52M, a 140.37% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-03-31 was -$1.36M, a 203.83% decline year-over-year.
- Crinetics Pharmaceuticals, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $28.98M, a 117.64% increase from fiscal 2024.
- Crinetics Pharmaceuticals, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $13.32M, a 7.77% increase from fiscal 2023.
- Crinetics Pharmaceuticals, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $12.36M, a 12.40% increase from fiscal 2022.
- Crinetics Pharmaceuticals, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $10.99M, a 74.70% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$2.77M 10-Q · filed 2026-08-03 | ||||
| 2026-03-31 | -$12.06M 10-Q · filed 2026-05-07 | |||||
| 2025-12-31 | $28.98M 10-K · filed 2026-02-26 | |||||
| 2025-06-30 | $12.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $11.16M 10-Q · filed 2026-08-03 | $15.25M derived: sum of 3 quarters · filed 2026-08-03 | $17.96M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-03-31 | -$1.36M 10-Q · filed 2026-05-07 | $2.73M derived: sum of 2 quarters · filed 2026-05-07 | $5.45M derived: sum of 3 quarters · filed 2026-05-07 | $10.65M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $4.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.80M derived: sum of 2 quarters · filed 2026-02-26 | $12.01M derived: sum of 3 quarters · filed 2026-02-26 | $13.32M 10-K · filed 2026-02-26 | $17.54M 10-K · filed 2025-02-27 | |
| 2024-09-30 | $2.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $7.92M derived: sum of 2 quarters · filed 2025-08-07 | $9.23M 10-Q · filed 2024-11-12 | $11.13M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $5.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $6.51M 10-Q · filed 2025-08-07 | $8.54M 10-Q · filed 2024-08-08 | $8.41M derived: sum of 3 quarters · filed 2026-02-26 | $12.80M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $1.31M 10-Q · filed 2025-05-08 | $3.21M derived: sum of 2 quarters · filed 2026-02-26 | $7.59M derived: sum of 3 quarters · filed 2026-02-26 | $15.01M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.28M derived: sum of 2 quarters · filed 2026-02-26 | $13.70M derived: sum of 3 quarters · filed 2026-02-26 | $12.36M 10-K · filed 2026-02-26 | $14.65M 10-K · filed 2024-02-28 | |
| 2023-09-30 | $4.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $11.80M derived: sum of 2 quarters · filed 2024-11-12 | $10.46M 10-Q · filed 2024-11-12 | $14.54M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $7.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $6.07M 10-Q · filed 2024-08-08 | $10.16M derived: sum of 3 quarters · filed 2025-02-27 | $8.83M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | -$1.34M 10-Q · filed 2024-05-09 | $2.74M derived: sum of 2 quarters · filed 2025-02-27 | $1.41M derived: sum of 3 quarters · filed 2025-02-27 | $8.12M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $4.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.75M derived: sum of 2 quarters · filed 2025-02-27 | $9.46M derived: sum of 3 quarters · filed 2025-02-27 | $10.99M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | -$1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $5.38M derived: sum of 2 quarters · filed 2023-11-07 | $6.91M 10-Q · filed 2023-11-07 | $10.81M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $6.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $8.24M 10-Q · filed 2023-08-08 | $12.14M derived: sum of 3 quarters · filed 2024-02-28 | $12.63M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $1.53M 10-Q · filed 2023-05-09 | $5.43M derived: sum of 2 quarters · filed 2024-02-28 | $5.92M derived: sum of 3 quarters · filed 2024-02-28 | $8.09M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $4.39M derived: sum of 2 quarters · filed 2024-02-28 | $6.56M derived: sum of 3 quarters · filed 2024-02-28 | $6.29M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $494.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.67M derived: sum of 2 quarters · filed 2022-11-14 | $2.40M 10-Q · filed 2022-11-14 | $4.31M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-06-30 | $2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $1.90M 10-Q · filed 2022-08-12 | $3.82M derived: sum of 3 quarters · filed 2023-02-28 | $3.06M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-03-31 | -$271.00K 10-Q · filed 2022-05-12 | $1.64M derived: sum of 2 quarters · filed 2023-02-28 | $892.00K derived: sum of 3 quarters · filed 2023-02-28 | $61.00K derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.16M derived: sum of 2 quarters · filed 2023-02-28 | $332.00K derived: sum of 3 quarters · filed 2023-02-28 | $2.72M 10-K · filed 2023-02-28 | ||
| 2020-09-30 | -$752.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$1.58M derived: sum of 2 quarters · filed 2021-11-05 | $808.00K 10-Q · filed 2021-11-05 | $1.48M derived: sum of 4 quarters · filed 2022-03-30 | ||
| 2020-06-30 | -$831.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $1.56M 10-Q · filed 2021-08-10 | $2.23M derived: sum of 3 quarters · filed 2022-03-30 | $2.35M derived: sum of 4 quarters · filed 2022-03-30 | ||
| 2020-03-31 | $2.39M 10-Q · filed 2021-05-06 | $3.06M derived: sum of 2 quarters · filed 2022-03-30 | $3.18M derived: sum of 3 quarters · filed 2022-03-30 | $2.50M derived: sum of 4 quarters · filed 2022-03-30 | ||
| 2019-12-31 | $674.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $788.00K derived: sum of 2 quarters · filed 2022-03-30 | $113.00K derived: sum of 3 quarters · filed 2022-03-30 | $696.00K 10-K · filed 2022-03-30 | ||
| 2019-09-30 | $114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$561.00K derived: sum of 2 quarters · filed 2020-11-06 | $22.00K 10-Q · filed 2020-11-06 | $2.90M derived: sum of 4 quarters · filed 2021-03-30 | ||
| 2019-06-30 | -$675.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$92.00K 10-Q · filed 2020-08-07 | $2.79M derived: sum of 3 quarters · filed 2021-03-30 | $3.62M derived: sum of 4 quarters · filed 2021-03-30 | ||
| 2019-03-31 | $583.00K 10-Q · filed 2020-05-08 | $3.46M derived: sum of 2 quarters · filed 2021-03-30 | $4.29M derived: sum of 3 quarters · filed 2021-03-30 | $6.07M derived: sum of 4 quarters · filed 2021-03-30 | ||
| 2018-12-31 | $2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $3.71M derived: sum of 2 quarters · filed 2021-03-30 | $5.49M derived: sum of 3 quarters · filed 2021-03-30 | $7.36M 10-K · filed 2021-03-30 | ||
| 2018-09-30 | $828.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $2.61M derived: sum of 2 quarters · filed 2019-11-12 | $4.48M 10-Q · filed 2019-11-12 | $4.49M derived: sum of 4 quarters · filed 2020-03-09 | ||
| 2018-06-30 | $1.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $3.65M 10-Q · filed 2019-08-13 | $3.66M derived: sum of 3 quarters · filed 2020-03-09 | $3.69M derived: sum of 4 quarters · filed 2020-03-09 | ||
| 2018-03-31 | $1.87M 10-Q · filed 2019-05-13 | $1.88M derived: sum of 2 quarters · filed 2020-03-09 | $1.90M derived: sum of 3 quarters · filed 2020-03-09 | |||
| 2017-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $33.00K derived: sum of 2 quarters · filed 2020-03-09 | $47.00K 10-K · filed 2020-03-09 | |||
| 2017-09-30 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $35.00K 10-Q · filed 2018-11-13 | ||||
| 2017-06-30 | $14.00K 10-Q · filed 2018-08-30 | |||||
| 2016-12-31 | $300.00K 10-K · filed 2019-03-13 |